- Compared with skipping a flu shot, getting a flu shot was associated with an 18 percent reduced risk of premature death among newly-diagnosed heart failure patients.
- Moreover, regular annual flu shots were associated with a 19 percent reduction in both all-cause and cardiovascular death when compared with no vaccination.
- Patients benefitted more when receiving flu shots received earlier in the year during September and October versus in November and December.
Embargoed until 4 a.m. CT / 5 a.m. ET Monday, December 10, 2018
DALLAS, Dec. 10, 2018 — Getting an annual flu shot can save heart failure patients’ lives, according to new research in the American Heart Association’s journal Circulation.
Flu season usually begins in the fall and runs through the spring, with cases often peaking during the winter months. Annual flu vaccination is regarded as a safe, low-cost way to reduce flu-related deaths and complications and is routinely recommended for patients with histories of heart disease and stroke. However, little is known about the possible impact a simple flu shot may have on the survival of heart failure patients.
Influenza can be very serious or even fatal for patients with heart failure because heart failure patients are often older than 65, have compromised circulation and other health complications, and infection may exacerbate heart failure symptoms. Moreover, heart failure is expected to increase over the next decade as the population ages, highlighting a greater need to provide better care for these patients.
In this study, researchers analyzed data on 134,048 patients with newly diagnosed heart failure over a 12-year period. Flu vaccination rates ranged from 16 percent in 2003 to 52 percent in 2015 with a peak of 54 percent in 2009. Among the researchers’ findings:
- Flu vaccination was associated with an 18 percent reduced risk of premature death, even after accounting for other factors such as medications, other health conditions, income and education.
- Annual flu vaccination following a heart failure diagnosis was associated with a 19 percent reduction in both all-cause and cardiovascular death when compared with no vaccination.
- Flu vaccination frequency mattered; getting a flu shot less than once per year but more than not at all was associated with a 13 percent reduced risk of all-cause death and an 8 percent reduced risk of cardiovascular death.
- Timing mattered; there was a greater reduction in cardiovascular and all-cause death when vaccination occurred earlier in the flu season during September and October versus in November and December.
Lead study author Daniel Modin, an investigator from the University of Copenhagen in Denmark, said that while this research only looked at patients with newly-diagnosed heart failure, the protection from a flu shot likely benefits any patient with heart failure.
“Recent studies have indicated that the influenza vaccination coverage of patients with heart failure is inadequate,” said Modin. “I hope that our study can assist in making physicians and cardiologists who care for patients with heart failure aware of how important influenza vaccination is for their patients. Influenza vaccination may be regarded as a standard treatment in heart failure similar to medications.”
Co-authors include Mads Jørgensen, M.D.; Gunnar Gislason, M.D., Ph.D.; Jan Jensen, M.D., Ph.D., D.M.Sci.; Lars Køber, M.D., D.M.Sci.; Brian Claggett, Ph.D.; Sheila Hegde, M.D., M.P.H.; Scott Solomon, M.D., M.P.H.; Christian Torp-Pedersen, M.D., D.M.Sci.; and Tor Biering-Sørensen, M.D., Ph.D., M.P.H. Author disclosures are on the manuscript.
Danish Heart Foundation funded the study.
- Available multimedia is located on the right column of the release link: https://newsroom.heart.org/news/regular-flu-shots-may-save-heart-failure-patients-lives?preview=eeabab24ee94825c8211ccbdcf443e72
- After December 10, view the manuscript online.
- For more information on heart failure, visit RiseAboveHF.org.
- Follow AHA/ASA news on Twitter @HeartNews
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at http://www.heart.org/corporatefunding.
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.
For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173
Carrie Thacker: 214-706-1665; firstname.lastname@example.org
For Public Inquiries: 1-800-AHA-USA1 (242-8721)